1cdd: Difference between revisions

New page: left|200px<br /><applet load="1cdd" size="450" color="white" frame="true" align="right" spinBox="true" caption="1cdd, resolution 2.8Å" /> '''STRUCTURES OF APO AND...
 
No edit summary
Line 1: Line 1:
[[Image:1cdd.gif|left|200px]]<br /><applet load="1cdd" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1cdd.gif|left|200px]]<br /><applet load="1cdd" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1cdd, resolution 2.8&Aring;" />
caption="1cdd, resolution 2.8&Aring;" />
'''STRUCTURES OF APO AND COMPLEXED ESCHERICHIA COLI GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE'''<br />
'''STRUCTURES OF APO AND COMPLEXED ESCHERICHIA COLI GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE'''<br />


==Overview==
==Overview==
The three-dimensional structure of phosphoribosylglycinamide, formyltransferase (10-formyltetrahydrofolate:5'-phosphoribosylglycinamide, formyltransferase, EC 2.1.2.2) has been solved both as an apoenzyme at, 2.8-A resolution and as a ternary complex with the substrate glycinamide, ribonucleotide and a folate inhibitor at 2.5-A resolution. The structure, is a modified doubly wound alpha/beta sheet with flexibility in the active, site, including a disordered loop in the apo structure, which is ordered, in the ternary complex structure. This enzyme is a target for anti-cancer, therapy and now for structure-based drug design.
The three-dimensional structure of phosphoribosylglycinamide formyltransferase (10-formyltetrahydrofolate:5'-phosphoribosylglycinamide formyltransferase, EC 2.1.2.2) has been solved both as an apoenzyme at 2.8-A resolution and as a ternary complex with the substrate glycinamide ribonucleotide and a folate inhibitor at 2.5-A resolution. The structure is a modified doubly wound alpha/beta sheet with flexibility in the active site, including a disordered loop in the apo structure, which is ordered in the ternary complex structure. This enzyme is a target for anti-cancer therapy and now for structure-based drug design.


==About this Structure==
==About this Structure==
1CDD is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with PO4 as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Phosphoribosylglycinamide_formyltransferase Phosphoribosylglycinamide formyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.1.2.2 2.1.2.2] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1CDD OCA].  
1CDD is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with <scene name='pdbligand=PO4:'>PO4</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Phosphoribosylglycinamide_formyltransferase Phosphoribosylglycinamide formyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.1.2.2 2.1.2.2] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1CDD OCA].  


==Reference==
==Reference==
Line 14: Line 14:
[[Category: Phosphoribosylglycinamide formyltransferase]]
[[Category: Phosphoribosylglycinamide formyltransferase]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Almassy, R.J.]]
[[Category: Almassy, R J.]]
[[Category: Hostomska, Z.]]
[[Category: Hostomska, Z.]]
[[Category: Janson, C.A.]]
[[Category: Janson, C A.]]
[[Category: Kan, C.C.]]
[[Category: Kan, C C.]]
[[Category: PO4]]
[[Category: PO4]]
[[Category: transferase(formyl)]]
[[Category: transferase(formyl)]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 12:21:54 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:04:51 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA